Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adia MedADIA +3.72%20 Earnings per Share (Diluted) is $0.00 as of Jun. 2026. GuruFocus rates ADIA with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 503 Healthcare Providers & Services companies, Adia Med ranks worse than 198806.96% on this metric.
Adia Med's EPS (Basic) for the
six
months ended in Jun. 2026 was $0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00.
Adia Med's EPS without NRI for the
six
months ended in Jun. 2026 was $0.00.
Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00.
Adia Med (OTCPK:ADIA) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Adia Med Earnings per Share (Diluted) Related Terms
Adia Med Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Adia Med's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADIA vs SYRA, GBCS, AMS: Earnings per Share (Diluted) Comparison
For the Medical Care Facilities subindustry, Adia Med's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adia Med PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Adia Med's PE Ratio distribution charts can be found below:
* The bar in red indicates where Adia Med's PE Ratio falls into.
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Adia Med's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2025 is calculated as
For stock reported annually, GuruFocus uses latest annual data as the TTM data. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.00 mean?
Adia Med (ADIA) has a Earnings per Share (Diluted) of $0.00 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Adia Med and its competitors. According to the industry distribution chart, Adia Med ranks #999999 out of 503 companies in the Healthcare Providers & Services industry.
Is Adia Med's Earnings per Share (Diluted) too high?
Adia Med's current Earnings per Share (Diluted) is $0.00. Based on the distribution chart, Adia Med ranks #999999 out of 503 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Adia Med has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Adia Med's Earnings per Share (Diluted) compare to SYRA and GBCS?
According to the Healthcare Providers & Services industry distribution chart, Adia Med ranks #999999 out of 503 companies for Earnings per Share (Diluted). This places Adia Med in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.00, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Adia Med and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adia Med's current Earnings per Share (Diluted) is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adia Med stock overvalued right now?
Adia Med (ADIA) has a current Earnings per Share (Diluted) of $0.00. The current Earnings per Share (Diluted) is $0.00. Adia Med's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Adia Med (ADIA), the current Earnings per Share (Diluted) is $0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Adia Nutrition Inc focus is to work closely with healthcare providers and health insurance companies to facilitate and provide Autologous Hematopoietic Stem Cell Transplantation (AHSCT). Its products and the deployment of the therapies utilizing its products address various orthopedic issues, pain management, and wound repair. In addition, its products are able to be utilized in various other therapies to address anti-aging issues and other tissue repair desires. It operates in three segments The Biolete segment comprises the sale of supplements; Adia Med performs stem cell treatments to patients; and Adia Labs procures and sells stem cell products to outside clinics or to Adia Med. It derives revenue from Sales of supplements, Medical procedures, Sales of biologics and ancillary products.
20GF Score
Get the complete analysis for ADIA
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADIA has been successfully added to your 
